Skip to main content
Navigate Up
Sign In

Welcome to the Department of Neurology

Neurology Banner Image
 

Movement Disorders

Clinical Trials



If you think you may qualify for one of these studies, please contact Professional Research Assistant (PRA) below for more information.

Search for: (view all)

Title Principal Investigator PRA
Functional Connectivity of the Basal Ganglia in Primary Focal Dystonia: A Pilot Project Berman, Brian D., MD, MS Erika Shelton
303-724-5865
Eligibility and Information
Functional Connectivity of the Motor Network in Two Major Subtypes of Parkinson Disease Berman, Brian D., MD, MS Erika Shelton
303-724-5865
Eligibility and Information
Natural History and Biospecimen Repository for Dystonia Berman, Brian D., MD, MS Erika Shelton
303-724-5865
Eligibility and Information
Neural Mechanisms of Reflexive Blinking and Eye Muscle Spasms in Blepharospasm Berman, Brian D., MD, MS Erika Shelton
303-724-5865
Please contact PRA for eligibility and information
Defining Palliative Care Needs in Parkinson’s Disease Kluger, Benzi M., MD, MS Isabel Boersma
303-724-2193
Please contact PRA for eligibility and information
Cortical physiology as a therapeutic target in Parkinson's disease related dementia and cognitive dysfunction Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Clinical Research Database for University of Colorado Health System's Outpatient Palliative Care Programs Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Pilot Investigation of Transcranial Magnetic Stimulation (TMS) as Treatment for Cortical Hyperexcitability Syndromes Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Study of the Neurophysiology of Central Fatigue Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Fatigability of Cognitive Performance in Older Adults: Objective Measures and the Impact on Quality of Life and Activity Level Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Movement Disorders and Behavioral Neurology Research Database Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Does prior acupuncture experience bias subjects’ perception of real versus sham acupuncture treatments? Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Cognitive Dysfunction in Parkinson's Disease Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Accuracy of PET Scans in the Diagnosis of Dementia in the Community Setting Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
University of Colorado Denver Depression Center Repetitive Transcranial Magnetic Stimulation (RTMS) Research Registry Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Test of a novel TMS method Kluger, Benzi M., MD, MS Kluger, Benzi M., MD, MS
303-724-4400
Please contact PRA for eligibility and information
Review of number of microelectrode recording passes performed during subthalamic nucleus deep-brain stimulation surgery Klepitskaya, Olga S., MD Wendi Legg
303-724-8305
Please contact PRA for eligibility and information
The Burden of Cerebral Diffuse Ischemic White Matter Disease, Measured Quantitatively on MRI, as a Possible Predictive Factor of Cognitive Outcomes after STN DBS Surgery for Parkinson Disease Klepitskaya, Olga S., MD Wendi Legg
303-724-8305
Please contact PRA for eligibility and information
Using Multiplex Families to Map Genes that Modify Susceptibility and Age at Onset in Parkinson's Disease (also known as "The PaGeR Study") Parkinson’s Genetic Research Study- NIH Klepitskaya, Olga S., MD Wendi Legg
303-724-8305
Eligibility and Information
A Phase 2B, Twelve-week Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study, To Determine the Safety, Tolerability and Efficacy of Two Doses of Once Daily P2B001 in Subjects With Early Parkinson’s Disease (PD) Klepitskaya, Olga S., MD Wendi Legg
303-724-8305
Eligibility and Information
A Phase 3b, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of DYSPORT Using 2mL Dilution in Adults With Cervical Dystonia Klepitskaya, Olga S., MD Wendi Legg
303-724-8305
Eligibility and Information
A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC (part A) Followed by an Open-Label, Multiple-Treatment Study with MYOBLOC (part B) in the Treatment of Troublesome Sialorrhea in Adult Subjects Klepitskaya, Olga S., MD Wendi Legg
303-724-8305
Eligibility and Information
A Phase 3b, Prospective, Multicenter, Open-Label Extension Study to Assess Long Term Safety and Effectiveness of DYSPORT Using 2mL Dilution in Adults with Cervical Dystonia Klepitskaya, Olga S., MD Wendi Legg
303-724-8305
Please contact PRA for eligibility and information
Trajectories and Markers of Neurodegeneration in Fragile X Premutation Carriers Leehey, Maureen A., MD Shannon Hall
303-724-2194
Please contact PRA for eligibility and information
Exploratory Study of Different Doses of Endurance Exercise in People With Parkinson Disease Margaret Schenkman, PT, PhD, FAPTA Toby Wellington
720-848-6376
Eligibility and Information